Mestinon retard, Tabletten
7680563870017
CH-56387
Tabletten
Associated product:
MESTINON cpr ret 180 mg 100 pce
1 / 3
google
Article details
- Package size
- 100
- Selling units
- 100
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
pyridostigmini bromidum
|
180.0 MG | Substance | Wirkstoff (Principe actif) |
|
cera carnauba
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
tricalcii phosphas
|
- | Substance | HNIDK |
|
zeinum
|
- | Substance | HNIDK |
Authorization holder
MEDA Pharmaceuticals Switzerland
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 56387
- Drug name
- Mestinon retard, Tabletten
- Galenic form
- TAB
- ATC Code
- N07AA02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 01/09/2010
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.14.0.
- Domain
- Human medicine
Package details
- Description (FR)
- MESTINON cpr ret 180 mg 100 pce
- Description (DE)
- MESTINON Ret Tabl 180 mg 100 Stk
- Market launch
- 01/09/2010
- Narcotic (BTM)
- No
Other package sizes (1)
MESTINON cpr ret 180 mg blist 100 pce
100 TABL
GTIN: 7680563870024